Inventor
DELISLE ROBERT KIRK
US19 patents
⚠️ This page may combine multiple inventors who share the name “DELISLE ROBERT KIRK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARRAY BIOPHARMA INC
9 patentsUS9221841B2Dec 29, 2015
Mitotic kinesin inhibitors and methods of use thereof
ARRAY BIOPHARMA INC5 citations83
US7795282B2Sep 14, 2010
Mitotic kinesin inhibitors and methods of use thereof
ARRAY BIOPHARMA INC9 citations83
US9556139B2Jan 31, 2017
6-substituted phenoxychroman carboxylic acid derivatives
ARRAY BIOPHARMA INC1 citations62
US9096567B2Aug 4, 2015
6-substituted phenoxychroman carboxylic acid derivatives
ARRAY BIOPHARMA INC2 citations62
US8716498B2May 6, 2014
6-substituted phenoxychroman carboxylic acid derivatives
ARRAY BIOPHARMA INC2 citations62
US9809590B2Nov 7, 2017
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors
ARRAY BIOPHARMA INC1 citations61
US10669269B2Jun 2, 2020
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors
ARRAY BIOPHARMA INC0 citations49
US8895550B2Nov 25, 2014
Triazolopyridine compounds as PIM kinase inhibitors
ARRAY BIOPHARMA INC0 citations40
US8987251B2Mar 24, 2015
Triazolopyridine compounds as PIM kinase inhibitors
ARRAY BIOPHARMA INC0 citations36
HANS JEREMY
2 patentsALLEN SHELLEY
2 patentsBOYS MARK LAURENCE
2 patentsUS9174981B2Nov 3, 2015
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors
BOYS MARK LAURENCE3 citations58
US8841455B2Sep 23, 2014
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cFMS inhibitors
BOYS MARK LAURENCE1 citations46